Our observational study demonstrated that in those subjects most vulnerable to B cell dysfunction (obese women with advanced maternal age and those administered a longer course of 17OHPC) the effects of exogenous progesterone seemingly overwhelm the compensatory mechanisms of insulin production and result in a higher frequency of gestational diabetes. The gene discussed is INS; the disease is gestational diabetes.